Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rivals threaten to take wind from Watson’s generic Lipitor sales
Med City
Wednesday, November 30, 2011 - 11:31am
tags:
Watson, generics, Pfizer, Lipitor, Teva Pharmaceuticals, Ranbaxy
Pfizer After Lipitor to Push Mini-Blockbusters
Bloomberg
Wednesday, November 30, 2011 - 11:29am
tags:
Pfizer, generics, Lipitor
Why There Will Never Be Another Drug Like Lipitor
Forbes
Wednesday, November 30, 2011 - 11:28am
tags:
Pfizer, generics, statins, Lipitor
GSK shakes up R&D units during high-profile review
Fierce Biotech
Wednesday, November 30, 2011 - 10:50am
tags:
GSK, R&D
New Drug Approvals Make Or Break Biotechnology Stocks
Seeking Alpha
Wednesday, November 30, 2011 - 10:46am
tags:
Antares, Achillion, Pharmasset, Indenix, Inhibitex, ONYX Pharmaceuticals, Keryx
Every Biotech Is for Sale
Motley Fool
Wednesday, November 30, 2011 - 10:45am
tags:
ONYX Pharmaceuticals, Achillion, BioSante, Indenix, Inhibitex, GSK, Bristol-Myers Squibb, Amarin, Exelixis
Forget The Rumors: Why Pfizer Might Be Incentivized To Acquire Lpath Outright
Seeking Alpha
Wednesday, November 30, 2011 - 10:43am
tags:
Lpath, Pfizer, M&A, lipid signaling
Onyx' Cancer Drug on Right Track
Yahoo/Zacks.com
Wednesday, November 30, 2011 - 10:37am
tags:
ONYX Pharmaceuticals, Carfilzomib, Multiple Myeloma
Novartis’s Lucentis Fails to Win Backing in Final U.K. Guidance
Bloomberg Businessweek
Wednesday, November 30, 2011 - 9:30am
tags:
Novartis, Lucentis, UK, diabetic macular edema
Watson Pharma Confirms Launch Of Generic Lipitor
WSJ Online
Wednesday, November 30, 2011 - 9:23am
tags:
Watson, generics, Lipitor, Pfizer, statins
FDA pins approval on new formulation of Ambien
Fierce Drug Delivery
Wednesday, November 30, 2011 - 9:22am
tags:
FDA, insomnia, Ambien, Transcept, Purdue, Intermezzo
Biologic Drugs: A Fast Growing Industry In The Making
Seeking Alpha
Wednesday, November 30, 2011 - 9:13am
tags:
biologics, Abbott Laboratories, Biogen Idec, Impax, Sangamo BioSciences
Pfizer aims to keep one-third of Lipitor pie
Reuters
Wednesday, November 30, 2011 - 9:11am
tags:
Pfizer, Lipitor, generics, statins
Ranbaxy Shares Decline Amid Uncertainty Over Lipitor Copy Sales
Bloomberg
Wednesday, November 30, 2011 - 9:10am
tags:
Lipitor, Ranbaxy, generics, statins, Pfizer
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tuesday, November 29, 2011 - 6:48pm
tags:
Roche, Avastin, breast cancer, Merck, GSK, Bristol-Myers Squibb, Eli Lilly, Teva Pharmaceuticals, Dr Reddy's, Watson, Seattle Genetics
Pfizer gets creative to preserve Lipitor's billions in sales as first US generic rivals hit
Yahoo/AP
Tuesday, November 29, 2011 - 6:07pm
tags:
generics, patents, Pfizer, Lipitor
Joining FDA, Canada pulls Avastin's breast cancer indication
Fierce Pharma
Tuesday, November 29, 2011 - 1:40pm
tags:
Canada, Avastin, breast cancer, Roche
5 Risky Biotechs With Serious Profit Potential
Seeking Alpha
Tuesday, November 29, 2011 - 1:37pm
tags:
Amgen, Gilead, Spectrum Pharmaceuticals, InterMune, ViroPharma
Appetite For Arena Stock May Increase Ahead Of Obesity Drug NDA Re-Submission
Seeking Alpha
Tuesday, November 29, 2011 - 11:38am
tags:
obesity, Arena Pharmaceuticals, lorcaserin
FierceBiotech's 2011 Women in Biotech
Fierce Biotech
Tuesday, November 29, 2011 - 11:14am
tags:
women, biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.